Biopharma giant AstraZeneca begins coronavirus dual-use antibody drug trial in UK

The drug known as AZD7442 has the potential to be given as a
preventative option for people exposed to the coronavirus, and to
treat and prevent disease progression in patients already infected by
the deadly virus.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/biopharma-giant-astrazeneca-begins-coronavirus-dual-use-antibody-drug-trial-in-uk/articleshow/77741876.cms

Comments

Post a Comment

Popular posts from this blog

Biotecnika Times Newsletter 25.10.2021 Tata Innovation Fellowship 2021, NCCS PhD Admission

Image
Biotecnika Times – Tata Innovation Fellowship 2021, NCCS PhD Admission Tata Innovation Fellowship 2021 For Life Sciences & Biotechnology – Download Biotecnika App to Apply Tata Innovation Fellowship 2021-22 – Biological, Life Sciences & Biotechnology. Interested and eligible applicants can check out all of the details on the same below NCCS PhD Admission 2022 March […] The post Biotecnika Times Newsletter 25.10.2021 Tata Innovation Fellowship 2021, NCCS PhD Admission appeared first on BioTecNika. http://dlvr.it/SBDQJZ
Read more

Biotecnika Times Newsletter 29.11.2021 NABI Research Training, National Cancer Tissue

Image
Biotecnika Times – NABI Research Training, National Cancer Tissue 4-6 Months Research Training With Project Opportunity at NABI – Apply On Biotecnika App NABI, Mohali has announced the notification for Opportunity for 4 to 6 months (Jan to June 2022) Research Training with project at NABI, Mohali. NABI Project Research Training Opportunity 2022 For Life […] The post Biotecnika Times Newsletter 29.11.2021 NABI Research Training, National Cancer Tissue appeared first on BioTecNika. http://dlvr.it/SDMy6K
Read more

From 9/11 to Covid-19: My 19 Years at PON

Event Date as Display String: Friday, December 11, 2020, 12:00pm - 1:00pm URL: https://www.pon.harvard.edu/events/my-19-years-at-pon/ Event Description: Gazette Classification: Special Events Organization/Sponsor: The Herbert C. Kelman Seminar on International Conflict Analysis and Resolution Speaker(s): <strong>Susan Hackley</strong><br /><em>Managing Director, Program on Negotiation at Harvard Law School</em> Cost: Free and open to the public Ticket Web Link: https://harvard.zoom.us/webinar/register/WN_1I_3AwjeQVikx0REdtatZA Contact Info: dlong@law.harvard.edu Harvard Key Required: No Link: https://www.pon.harvard.edu/events/my-19-years-at-pon/ Donna Hicks, chair of the Herbert C. Kelman Seminar, will interview Susan Hackley, who has managed the Program on Negotiation at Harvard Law School since 2001. Under Susan's leadership, PON has significantly increased its outreach to people around the world through innovative prog...
Read more